Corrigendum to “A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD” [Respir. Med. 120 November 2016 16–24]
Keyword(s):
Keyword(s):
2018 ◽
Vol 49
◽
pp. 67-74
◽
Keyword(s):
2018 ◽
Vol 53
◽
pp. 33-38
◽
Keyword(s):
Keyword(s):